Julie Sunderland is the Managing Director of Biomatics Capital, a $200 million venture capital fund investing in breakthrough science and technology that will transform the practice of medicine and delivery of healthcare, especially in the genomics and digital health sectors. Until recently, Julie was the Director of Program Related Investments for the Bill & Melinda Gates Foundation, where she was responsible for managing the foundation’s $1.5 billion program-related investment (PRI) pool which focuses on strategic investments in global health, global development, and US education. Ms. Sunderland founded the PRI program in 2009 as a $400 million pilot and grew the portfolio to 50 investments comprising a range of investment structures (equity, loans, guaranties, funds), sectors (biotech, health commodities, health delivery, agriculture, digital payments, charter schools, education technology), and geographies (US, Europe, Africa, India, China). She built and led a team of 10 investment professionals and chaired the foundation’s investment committee that reviews all program-related investments undertaken by the foundation.

Julie holds a BA from Harvard University, an MBA from Wharton Business School and an MA from Johns Hopkins School of Advanced International Studies.

Fund's investment verticals: Consumer Services, Healthtech